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Abstract
Nowadays, obesity is considered as one of the fastest escalating nutritional 
disorders that reached pandemic throughout the world. Obesity is a condition in 
which overaccumulation of energy in the form of fat happens in an individual’s 
subcutaneous and/or abdominal visceral tissue. It is described as an abnormal 
growth of adipose tissue due to the enlargement of fat cell size (hypertrophic 
obesity) or fat cell number (hyperplastic obesity) or a condition of both. Earlier, it 
was reported that the most common type of obesity that affects the general popula-
tion is the polygenic form that results from a result of a positive energy balance 
between energy consumption and its expenditure – or a combination of both. The 
pandemic of obesity has enforced to analyze the link between the role of inflamma-
tion and complications of overweight and obesity. This led to crossroads of the field 
of nutrition, diet therapy, physiology, immunology, and epidemiology and makes 
the understanding that they are linked inexplicably. The remodeling of obesity as an 
inflammatory state has led a wide impression in our conceptualization of obesity-
related diseases. In this chapter, we highlight the endocrine aspect of adipose tissue, 
the effect of dysregulated secretion of adipokines due to inflammation and dietary 
components that affect obesity related to inflammation.
Keywords: nutritional disorder, obesity, adipokines, inflammation, 
dietary components
1. Introduction
A famous ancient proverb states that “Eat breakfast like a king, lunch like a 
prince, and dinner like a pauper.” In today’s era, these words have long been dis-
carded. The magnitude of obesity has reached in pandemic proportion due to new 
technology and modern life, which makes life easier and less active along with the 
intake of high energy dense food for better taste [1–3]. This is one of the biggest 
public health concerns of today’s era, which affects the individual not only physi-
cally but also physiologically and psychologically.
The World Health Organization (WHO) has reported that obesity has been 
growing at an alarming rate worldwide and has nearly been tripled between 1975 
and 2016. It was also reported by WHO in the year 2016 that more than 1.9 billion 
adults, 18 years and older, were overweight; of these over 650 million were obese 
(https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight) [4].
Nowadays, obesity is regarded as a complex dysfunctional neuroendocrine 
problem in which genetic makeup and environmental factors act in concert. 
The nongenetic risk factors encompass a wide range of social, physiological, 
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environmental, and behavioral factors. Sedentary lifestyle and overconsumption 
of high-fat and energy dense foods are a major contributor to energy imbalance. 
The altered phenomenon of hunger and satiety, lack of physical activity, decreased 
thermogenesis, and resting metabolic rate over a long period of time may lead to the 
energy imbalance.
In addition, other external factors such as age, gender, food preference, break-
fast skipping, medications, chemical toxicity, disorders of the endocrine system, 
socioeconomic status, and a psychological factor may give rise to weight gain prob-
lems. It is considered as a major contributor to the global burden of chronic diseases 
like hypertension, type 2 diabetes, hypercholesterolemia, heart diseases, insulin 
resistance, atherosclerosis, ischemic heart diseases, respiratory diseases, orthopedic 
disorders, several types of cancer, hormonal imbalance, disability, and many other 
diseases. Overweight and obesity also play a pivotal role in the development of 
low-grade inflammation, which contribute to the development of obesity-linked 
disorders, in particular to metabolic dysfunction [5]. However, a growing body of 
knowledge suggests that a possible convergence of an inflammatory state, which 
results in chronic inflammation and oxidative stress, is localized within adipose 
tissue [6] as shown in Figure 1. Adipose tissue inflammation plays a crucial role in 
promulgating obesity-related metabolic complications including the development 
of insulin resistance [6–8].
2. Adipose tissue: manager of inflammation
Over the past decades, it is well established that adipose tissue is not merely a 
fat storage depot but has been recognized as an endocrine organ capable of pro-
ducing various bioactive substances. It then became evident that white adipose 
tissue (WAT) secretes ample of peptides. Few of them regulate the inflammatory 
Figure 1. 
Overnutrition (overconsumption of high-fat and energy dense foods), lack of physical activity, sedentary 
lifestyle, and genetic susceptibility are the leading factors associated with the development of obesity. In 
addition to dysfunctional angiogenesis, an obese state is characterized by an abnormal inflammatory response, 
low antioxidant capacity, and reduced insulin sensitivity that may eventually lead to the generation of 
inflammation, oxidative stress, and insulin resistance. The figure was modified from the following review paper 
by Dludla et al. [6].
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processes such as leptin and adiponectin, whereas others are well-known cytokines 
such as interleukin (IL)-6, IL-1 and its receptor antagonist (IL-1Ra), and tumor 
necrosis factor (TNF)-α [9]. As we know, obesity is one of the major causes of 
atherosclerosis, which is recognized as a chronic vascular inflammatory process in 
which cytokines and chemokines play a dramatic role [9–10]. White adipose tissue 
plays an important role in metabolism and inflammation as illustrated in Figure 2.
Cytokines are categorized as interleukins, interferons, chemokines, hemato-
poietic factors, and growth factors. They are knotted in many biological processes 
such as growth, differentiation, cell division, apoptosis, immunity, and inflam-
mation [9]. Cytokines are produced by numerous cell types of the hematopoietic 
lineage including T cells, B cells, mast cells, macrophages, dendritic cells, and 
natural killer cells. In spite of these, cytokines are also produced by nonhemato-
poietic cells such as epithelial cells, hepatocytes, and fibroblasts [9, 12]. Evidence 
revealed that IL-1, IL-6, and TNF-α are characterized as a proinflammatory cyto-
kine that activates both acute and chronic inflammatory responses [9]. Inhibitors 
that control inflammation can be categorized as anti-inflammatory cytokines, 
soluble receptors to cytokines, and naturally occurring proteins. Types of anti-
inflammatory cytokines are IL-10, IL-4, and TGF-β; soluble receptors to cytokines 
are IL-1 and TNF-α; and naturally occurring proteins are IL-1Ra receptors. The 
classification of cytokines is depicted in Figure 3.
Chemokines are a type of cytokine that is a part of family molecules that are 
indulged in the chemotaxis of inflammatory cells via the generation of local concen-
tration gradients. Chemokines play an important role in various physiological and 
pathological processes such as cell recruitment process and development of lym-
phoid organs or metastases. In spite of these, chemokines also participate in meta-
bolic and inflammatory disorders such as rheumatoid arthritis, glomerulonephritis, 
Figure 2. 
Adipose tissue is a metabolically dynamic, highly active endocrine organ. White adipose tissue (WAT) produces 
a large variety of proteins regulating metabolism and inflammation, contributing to the maintenance of energy 
homeostasis and, probably, the pathogenesis of obesity-related metabolic and vascular complications. The figure 
was modified from the following research paper by Juge-Aubry et al. [9]. The following website was used for the 
extraction of image: https://scitechdaily.com/gc-1-turns-white-fat-brown-fat/ [11].
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and atherosclerosis via their innate ability to recruit and activate the inflammatory 
cells [9]. They are categorized into four subclasses according to the position of 
their cysteines (CXC, C, CX3C, and CC) [9, 13]. Chemokines that are produced 
from WAT are interferon-γ inducible protein 10 (IP-10 or CXCL10) and IL-8 
(or CXCL8) belong to the CXC chemokines, while monocyte chemo-attractant 
protein-1 (MCP-1 or CCL2) and regulated upon activation normal T-cell express 
sequence (RANTES or CCL5) are CC chemokines [9, 13]. Previous studies showed 
that chemokines are paracrine rather than systemic factors, the significance of 
their secretion via adipose tissue may be seen in the context of fat depots found in 
close proximity to their target tissues, for example, subcutaneous fat in inflamma-
tory skin diseases, perivascular adipose tissue in obesity-associated cardiovascular 
diseases, and perirenal fat in glomerulonephritis [9, 14].
In addition, several other metabolically important proteins with immunomodu-
latory actions are secreted by adipose tissue, including leptin, adiponectin, and 
resistin. The dysregulated expression of these factors, caused by excess adiposity 
and adipocyte dysfunction, has been linked to the pathogenesis of various disease 
processes through altered immune responses. As such, much attention has been 
paid to develop a better understanding of the immunoregulatory functions of adi-
pose tissue. New factors secreted by adipose tissue have been identified that either 
promote inflammatory responses and metabolic dysfunction or contribute to the 
resolution of inflammation and have beneficial effects on obesity-linked metabolic 
disorders. These findings lend additional support to the notion that an imbalance 
of pro- and anti-inflammatory adipokines secreted by adipose tissue contributes to 
metabolic dysfunction [5].
3. Obesity: state of low-grade inflammation
Obesity is associated with alterations in immunity, a chronic low-grade inflam-
mation, which is characterized by abnormal secretion of adipokines, that is, there 
is an increment in circulating proinflammatory cytokines and a decrement in 
anti-inflammatory cytokines. It is also linked with alteration in immunity. However, 
Figure 3. 
Classification of cytokines. (a) Classes of inflammatory cytokines. (b) Anti-inflammatory mediators. The 
figure was modified from the following research paper by Juge-Aubry et al. [9].
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with the reduction in body weight, these parameters may reverse or come to the 
normal level. Although, it is still debatable how obesity triggers inflammation. 
Earlier, several hypotheses were proposed regarding the inflammation of obesity. 
The first one stated that overburden of nutrients in the adipocytes leads to intracel-
lular stress that results in the stimulation of inflammatory cytokines [15–17].
The excessive nutrients may lead to aggregation of unfolded proteins in the 
endoplasmic reticulum (ER) via activation of the unfolded protein response (UPR) 
pathway [15, 17]. The pathway of UPR depends on basically three main sensors 
of ER, that is, PKR-like eukaryotic initiation factor 2α kinase (PERK), inositol-
requiring enzyme 1 (IRE-1), and activating transcription factor 6 (ATF-6) [15, 18]. 
The activity of the C-Jun amino-terminal kinase (JNK) and inhibitor of IκB (IKK-β), 
serine-phosphorylation of insulin-receptor substrate protein 1 (IRS-1), and the 
nuclear factor-κB (NF-κB) pathway may increase by the activated sensors of ER that 
results in increased expression of proinflammatory cytokines [15–16, 19–21].
The second hypothesis enumerates that overburdened adipocytes with fat cells 
intensely increase the infiltration of macrophages, which may lead to subsequent 
differentiation and activation of cytotoxic T cells. As a result, initiation and 
propagation of inflammatory cytokines cascades occur [15, 22]. Third hypothesis 
proposes that as during obesity, enlargement of adipose tissue happens as a result 
tissue becomes relatively hypoxic. Hypoxia within the adipose tissues results in the 
activation of inflammatory pathways [15, 23–24]. Above all, the last hypothesis 
suggests that overburdened adipocytes themselves may directly activate immune 
pathogen sensors that result in chronic inflammation [15, 25].
4. Dietary components that affect obesity related to inflammation
The analysis of dietary intake is an approach to investigate a link between diet 
and overweight and obesity-related inflammation. Various studies reported that 
bioactive nutrients and dietary non-nutrients strongly influence health, metabo-
lism, and progression of pathologic states that ultimately result in chronic degen-
erative diseases [26]. Many studies indicate that diet may affect body weight by 
controlling satiety and metabolic efficiency or by harmonizing insulin secretion and 
action [3, 27]. It is an essential key factor for immune response. Earlier, evidence 
revealed that undernutrition brings about immunosuppression due to susceptibility 
to infection. Whereas, overnutrition brings about immunoactivation due to suscep-
tibility to inflammatory diseases. As a result, optimum nutrition is mandatory for a 
healthy immune balance of an individual [15] as shown in Figure 4.
Dietary components play an important role in obesity-related inflammation as 
enumerated below:
4.1 Carbohydrates
Carbohydrates are the main food source of a living organism and a major source 
of energy. Carbohydrates are also known as energy giving foods. The source of 
energy was estimated based on their glycemic index (GI) or glycemic load (GL) 
values. GI is the value given to the foods on how quickly they increase the glucose 
level postprandially and measures the quality of carbohydrate. GL calculates both 
the quality and quantity of carbohydrates [15, 28]. Earlier studies reported that, 
positive correlation exists between dietary GI and GL and biomarkers of inflam-
mation because a low GI diet decreases the rate of glucose absorption in the body 
that subsequently reduces hyperglycemia and hyperinsulinemia that results in the 
reduction of systemic inflammation. Earlier, it was also reported that weight loss 
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leads to improvement in insulin sensitivity and a reduction in the level of proin-
flammatory cytokines. Various health organization also reported that low GI diets 
help in managing diabetes and coronary heart diseases and considered as a weapon 
against obesity [29–30].
Neuhouser et al. [31] revealed from randomized, crossover feeding study 
that respondents with high-fat mass (>32.0% for male and >25.0% for female) 
showed reduced CRP (P = 0.02) and marginally increased adiponectin (P = 0.06). 
Therefore, it was concluded that the quality of carbohydrates independent of 
energy was very important as low-GL foods improve the inflammatory and adi-
pokine profiles of overweight and obese individuals [31]. Another study done by 
Levitan et al., among women (n = 18,137, >45 years of age), reported that diets 
characterized by lower GI and GL were associated with somewhat more favorable 
lipid profiles and lower CRP [32]. Interestingly, one of the epidemiological stud-
ies done by Vrolix and Mensick found that consumption of a diet with decreased 
GL does not decrease the metabolic risk parameters in overweight subjects [33]. 
Another study done by Kelly et al. also supports the above findings, that is, it does 
not found any additional benefit of including a low glycemic diet with exercise on 
insulin sensitivity and adipokine concentrations [34]. Above all, it may be stated 
that observational studies showed a positive association between intake of GI/GL 
diet and markers of inflammation. However, interventional studies do not found 
such an association.
4.2 Dietary fat
Fat is also one of the important sources of energy that serves both structural 
and metabolic functions of living organisms. The excessive accumulation of fat in 
the body leads to impairment of the immune system. A number of fatty acids have 
been studied including saturated, trans-fatty acids, and polyunsaturated fatty acids 
(PUFA) for their effect on inflammatory status [15].
4.2.1 Polyunsaturated fatty acids
The omega-3 (n-3) and omega-6 (n-6) PUFA families are precursors of 
eicosanoids, which play a vital role in the immune response [15]. Simpoulos [35] 
Figure 4. 
Healthy immune balance between undernutrition and overnutrition. The figure was modified from the 
following research paper by Lee et al. [15].
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stated that high omega-6 fatty acids increase leptin and insulin resistance, whereas 
omega-3 fatty acids lead to homeostasis and weight loss. This is so because the high 
omega-6/omega-3 ratio is associated with overweight/obesity, whereas a balanced 
ratio decreases obesity and weight gain [35]. Another study showed that an increase 
in the intake of n-6:n-3 PUFA potentiates the inflammatory processes that ulti-
mately lead to many inflammatory diseases such as nonalcoholic fatty liver disease 
(NAFLD), cardiovascular disease, diabetes, obesity, inflammatory bowel disease 
(IBD), rheumatoid arthritis, and Alzheimer’s disease. This change in the ratio of 
consumption of n-3/n-6 fatty acids changes the production of important mediators 
and regulators of inflammation and immune response that leads toward the pro-
inflammatory state. Hence, it was concluded in the study that increasing the ratio 
of (n-3)/(n-6) PUFA in the diet may lead to a reduction in the incidence of chronic 
inflammatory diseases [36].
A clinical trial and in-vitro experiment study reported that supplementation 
of fish oil delineates the expression of adipose inflammatory genes including 
inflammasome-associated IL-18 and IL-1b and circulating IL-18 levels. In spite of 
this, it was also stated that both eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) decrease the inflammasome gene expression in obese human adipose 
and human adipocyte and macrophages [37]. Above all, various studies concluded 
that omega-3 fatty acids, namely EPA and DHA, have an anti-inflammatory effect.
4.2.2 Trans and saturated fatty acids
A review study was done by Rogero and Calder stated that saturated fatty acids 
induce inflammation by activating the TLR4 signaling pathway (TLR4 signaling 
pathway is recognized as the main pathway that triggers in obesity-induced inflam-
mation) [38]. Another study revealed that the ingestion of excessive amounts 
of trans-fatty acids and saturated fatty acids is considered to be a risk factor for 
metabolic and degenerative diseases. It was also emphasized that saturated and 
trans-fatty acids favor a proinflammatory state leading to insulin resistance. 
These fatty acids can be indulged in several inflammatory pathways, contributing 
to disease progression in chronic inflammation, autoimmunity, allergy, cancer, 
atherosclerosis, hypertension, and heart hypertrophy as well as other metabolic and 
degenerative diseases. As a consequence, intake of dietary saturated and trans-fatty 
acids leads to lipotoxicity in several target organs by direct effects, represented by 
various inflammatory pathways, and through indirect effects, including an impor-
tant alteration in the gut microbiota associated with endotoxemia process [39].
4.3 Fruits and vegetables
Fruits and vegetables comprise a myriad of nutrients, that is, vitamins, minerals, 
and many food compounds that have been inversely correlated with metabolic risk 
factors such as oxidative stress and inflammation. In a randomized controlled trial 
study, it was found that fruits and vegetables reduce the risk of metabolic disease 
that may be via modulation of gut microbiota. The study also revealed that fruits 
and vegetables decrease the secretion of interleukin-6 (IL-6) and lipopolysaccha-
ride-binding protein (LBP) [40]. Another study done by Navarro et al. through fac-
tor analysis found that dietary patterns loaded with fruits and vegetables strongly 
negatively correlated with the secretion of hs-CRP among prepubertal girls [41]. An 
almost similar result was observed by Julia et al. that dietary pattern characterized 
by intake rich in vegetable and vegetable oil leads to the supply of essential fatty 
acids and antioxidant micronutrients showed a negative correlation with the risk 
of elevation of CRP [42]. Another cross-sectional study done on a group of 7574 
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Koreans found that an inverse correlation exists between vegetable pattern and CRP 
and the association appeared to be more predominant in men having hypertensive 
blood pressure [43]. Surprisingly, the study done by Salas-Salvado et al. (n = 772, 
55–80 years of age) and Freese et al. (n = 77, 19–52 years of age) did not found any 
association between a diet rich in vegetables and fruits with inflammatory markers 
[adiponectin, CRP, IL-6, intercellular adhesion molecule-1 (ICAM-1), and vascular 
cell adhesion molecule-1 (VCAM-1)] [15, 44–45]. Another study done by Morand 
et al. (n = 24, mean age of 56 years) also showed a similar pattern of above finding 
that a single fruit supplementation (500 mL of orange juice/d for 4 weeks) did not 
change the levels of CRP, IL-6, ICAM-1, and VCAM-1 [15, 46].
4.4 Other nutrients
Oxidative stress and imbalance in immune responses play a crucial role in the 
development of obesity and its associated comorbidities. Various epidemiological 
shown that several vitamins and minerals have a favorable response on the level of 
inflammatory markers, that is, CRP, IL-6, and TNF-α.
4.4.1 Vitamin A
Various cross-sectional and intervention studies reported regarding over-
weight and obese respondents that they have lower circulating carotenoids in the 
plasma because of a high proportion of carotenoids, as lipid-soluble compounds, 
being stored in adipose tissue [15, 47]. The Women’s Health Study (n = 2895, aged 
≥45 years of age) reported that higher plasma concentrations of α- and β-carotene 
were associated with low levels of plasma CRP. In spite of this, plasma carotenoids 
were associated with obesity, HDL-cholesterol, LDL-cholesterol, HbA1c, and smok-
ing [15, 48]. Another study done by Julia et al. suggested that the β-carotene status 
was inversely associated with low-grade inflammation [49]. Another cross-sectional 
meta-analysis study focusing on Syndrome X respondents showed an inverse asso-
ciation between total plasma carotenoids and metabolic syndrome. Respondents 
with the highest total circulating carotenoids had a 24% reduced risk for developing 
metabolic syndrome. Interestingly, when, individual carotenoids were included, 
and significant associations were found for β-carotene, lycopene, α-carotene, and 
β-cryptoxanthin [50–51].
4.4.2 Vitamin C
Vitamin C is effective in strengthening the immune system, capillary blood 
vessels, and protecting the dental health, as well as in the convenient use of iron, 
calcium, thiamine, riboflavin, folic acid, and vitamins A and E in the body. Vitamin 
C also acts as a cofactor for 15 different enzymes and shows the antioxidant activity 
as an electron donor reducing agent. It acts as a powerful free radical scavenger by 
protecting tissues against oxidative stress and reduces inflammation [52]. Totan 
et al. reported that vitamin C reduces the systemic inflammation by inhibiting CRP 
and TNF-α pathways. In spite of this, vitamin C inhibits hypoxia in adipose tissue 
that has the potential for protection against free radicals and decreasing lipid per-
oxidation. On the other hand, the study also revealed that vitamin C inhibits mature 
adipocyte formation and cell growth, inhibits lipolysis, and can be considered as a 
treatment model for obesity to offer solutions for abnormal fat accumulation [52]. 
Another study reported that vitamin C may improve inflammation by reducing the 
pro-inflammatory and inflammatory markers such as CRP, IL-6, and TNF-α [53]. 
Additionally, Fumeron et al. reported in the prospective, randomized, open-label 
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trial study (n = 42, 18–80 years of age) that vitamin C supplementation (750 mg/d 
for 8 weeks) did not change blood levels of CRP [15, 54].
4.4.3 Magnesium
Magnesium is the second most abundant intracellular cation and is involved in 
about 300 biochemical reactions related to anabolic and catabolic actions in the 
body, such as glycolysis and protein and lipid metabolism [55–56]. The Women’s 
Health Initiative Observational Study (n = 3713 postmenopausal women, aged 
50–79 years) reported that intake of dietary magnesium was independently and 
inversely associated with plasma concentrations of hs-CRP, IL-6, and sVCAM-1 in 
postmenopausal women after an adjustment for multiple variables including 
dietary fiber, fruit, vegetables, folate, and saturated and trans-fatty intake [57]. 
Another study done by Guerrero-Romero and Rodriguez- Moran found that low 
serum Mg levels were independently related to elevated CRP concentration, in 
nondiabetic, nonhypertensive obese subjects (n = 371) [15, 58].
4.4.4 Flavonoids
Flavonoids, a group of natural substances with variable phenolic structures, 
are found in fruits, vegetables, grains, bark, roots, stems, flowers, tea, and wine. 
Nowadays, flavonoids are considered essential components in various applications 
such as nutraceutical, pharmaceutical, medicinal, and cosmetic. This is attributed 
to their anti-oxidative, anti-inflammatory, anti-mutagenic, and anti-carcinogenic 
properties coupled with their capacity to modulate key cellular enzyme function 
[59]. According to National Health and Nutrition Examination Survey (NHANES), 
a large, cross-sectional survey National Centre for Health Statistic (n = 9551 adults) 
showed that flavonoid consumption was inversely associated with obesity in both 
men and women in multivariate models. It was also observed that adults in the high-
est quartile of flavonoid intake had significantly lower body mass index and waist 
circumference than those in the lowest quartile of flavonoid intake (P < 0.03 and 
P < 0.04, respectively). The study also revealed that flavonoid intake was inversely 
related to C-reactive protein levels in women (p-trend, 0.01) [60]. The Nurses’ 
Health Cohort Study (n = 2115 women, aged 43–70 years) reported that among 
flavonoid-rich foods, higher intake of grapefruit was significantly associated with 
lower concentrations of CRP and sTNF-R2. In spite of this, it was also reported 
in the study that flavonoids typically found in citrus fruits were modestly associ-
ated with lower plasma IL-18 concentrations [61]. Interestingly, a double-blind, 
placebo-controlled crossover study (n = 14, 35–53 years of age) reported that the 
supplementation of sea buckthorn flavonol extract for 4 weeks did not reduce CRP 
levels (p < 0.05) [15, 62].
4.4.5 Phytoestrogens
Phytoestrogens are plant-derived dietary compounds found in beans, seeds, 
and grains. The structure of phytoestrogens is similar to 17-β-oestradiol (E2), the 
primary female sex hormone. This structural similarity to E2 enables phytoestro-
gens to cause (anti) oestrogenic effects by binding to the oestrogen receptors [63]. 
Phytoestrogens had so many health benefits such as a lowered risk of menopausal 
symptoms such as hot flushes and osteoporosis, obesity, metabolic syndrome, and 
type 2 diabetes and lowered risks of cardiovascular disease, brain function disor-
ders, breast cancer, prostate cancer, bowel cancer, and other cancers [63]. A ran-
domized crossover clinical trial for 8 weeks (n = 42, postmenopausal women with 
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metabolic syndrome) reported that soy nut consumption reduces interleukin-18 
[64]. On the other hand, in a randomized, double-blind, controlled trial study 
(n = 50, post-menopausal women age = 58 ± 5 years), it was found that supplemen-
tation of soy isoflavone for 6 months had no effects on plasma CRP level [65].
4.4.6 Probiotics, prebiotics and synbiotics
According to the Food and Agriculture Organization of the United Nations 
(FAO) and WHO, probiotics are defined as “live microorganisms which, when 
administered in adequate amounts, confer a health benefit on the host” [66–67]. 
Earlier studies reported that probiotic bacteria, when administered orally, are able 
to modulate the immune system; however, differences exist in the immunomodula-
tory effects of different probiotic strains [15]. A randomized, double-blind, and 
placebo-controlled parallel-group intervention study compared Lactobacillus rham-
nosus with Bifidobacterium animalis ssp. Lactis Bb12 and Propionibacterium freuden-
reichii ssp. Shermanii JS for 3 weeks in healthy respondents (n = 81, 23–58 years of 
age). The study showed no effect on serum levels of TNF-α, IL-6, IL-10, or IFN-γ 
but a decreased level of CRP in the L. rhamnosus supplementation group [15, 68].
According to FAO/WHO, prebiotics is defined as “non-digestible food ingre-
dients that beneficially affect the host by selectively stimulating the growth and/
or activity of one or a limited number of bacterial species already established in the 
colon, and thus improve the host health” [67, 69]. Russo et al. reported in the study 
that intake of 11% enriched inulin-enriched pasta for 5 weeks improved lipidic and 
glicidic metabolism as well as insulin resistance in healthy young subjects [70]. 
Another study reported that intake of oligofructose (type of prebiotics) supple-
mentation (8 g/day for 3 weeks) in the elderly (n = 19, mean age = 85 years) showed 
a decrease in the expression of IL-6 mRNA in peripheral blood monocytes [71]. In 
contrary to the above study, the intervention study showed that supplementation 
of oligofructose (1.95–3.9 g/day for 12 weeks) did not affect plasma levels of IL-6 or 
TNF-α in poorly nourished elderly subjects (mean age of 70 years) [15, 72].
Synbiotics are defined as a combination of suitable probiotics and prebiotics 
that enhances survival and activity of the organism, for example, a fructooligosac-
charide (FOS) in conjunction with a Bifidobacterium strain or lactitol in conjunc-
tion with Lactobacillus strains [73–74]. Ferrarese et al. reported in the study that 
diet supplementation with Synbiotics prepared using selected strains (such as 
Lactobacillus gasseri strains) showed to exert weight reduction and anti-inflam-
matory activity. In spite of this, it was also concluded that their administration, 
together with galactomannan and/or inulin fibers, may increase weight manage-
ment effects due to synergistic effect on short-chain fatty acid production and 
microbiota “re-configuration” [75].
5. Discussion
The pandemic of obesity and its associated comorbidities derives our attention 
to the mechanism associated with a pathological condition. Earlier investigations 
revealed how cells and tissues respond to the stress of overnutrition and about the 
interplay between adipose tissue and other cell types that are critically involved 
in energy homeostasis. These findings also suggest the inflammatory response of 
obesity that might be beneficial or harmful, depending on the stage and degree of 
obesity, as well as other factors [76]. Previously, it was also reported that obesity 
and its associated comorbidities are due to intermingled interactions between 
11
Weight Management – Inflammation
DOI: http://dx.doi.org/10.5772/intechopen.92380
genetic, metabolic, and environmental factors in which dietary pattern plays a 
central role [77].
The current review is a narrative review of the impact of inflammation on 
weight management. In this review, a model is outlined in which inflammation is 
closely associated with obesity. However, this is a simplified view. Earlier studies 
reveal that severely underweight people such as patients with anorexia nervosa 
(AN) also display an overproduction of inflammatory cytokines. Dalton et al. 
reported from an exploratory cross-sectional study that interleukin (IL)-6, IL-15, 
and vascular cell adhesion molecule (VCAM)-1 concentrations were significantly 
elevated, and concentrations of BDNF (brain-derived neurotrophic factor), tumor 
necrosis factor (TNF)-β, and vascular endothelial growth factor (VEGF)-A were 
significantly lower in anorexia nervosa (AN) participants [78]. An almost simi-
lar result was reported through meta-analysis by Solmi et al. that patients with 
anorexia nervosa (AN) have increased TNF-α, IL6, IL1-β, and TNF-R-II levels but 
decreased C-reactive protein and IL-6R [79]. Earlier studies also reported that 
immunosuppressive medications such as corticosteroids lead to visceral adipos-
ity. Galitzky and Bouloumie reported that long-term exposure of glucocorticoids 
(GCs), either due to anti-inflammatory and immunosuppressive therapies or 
endocrine disturbances, accumulation of abdominal fat was observed in individu-
als with Cushing syndrome [80]. Lee et al. stated in the study that glucocorticoids 
(GCs) have profound effects on adipose tissue, adipogenesis, adipose tissue 
metabolic, and endocrine function. In the study, it was found that glucocorticoids 
(GCs) have multiple, depot-dependent effects on adipocyte gene expression and 
metabolism that enhances central fat deposition and lead to visceral obesity [81]. 
Further, contradicting study results are not included in the current study in order to 
provide a stringent model. Additionally, due to the limited space, important aspects 
of the topic such as physical activity and its influence on body weight regulation and 
cytokine production in detail are not included in the current study.
6. Conclusion
As we know that obesity is the condition of excessive accumulation of fat as a 
result of disequilibrium between energy intake and its expenditure. Several studies 
showed that adipose tissue acts as an endocrine organ that plays a critical role in 
maintaining the homeostasis of immunity. Studies also reported that obesity plays 
a pivotal role in the development of low-grade inflammation. As a result, optimal 
nutrition is required for maintaining a healthy immune balance. A healthy diet 
comprising of appropriate GI/GL, n-3 PUFAs, less amount of saturated and trans-
fatty acids, vitamins, minerals, flavonoids, phytoestrogens, probiotics, prebiotics, 
and Synbiotics is beneficial in combating the obesity and its related complications.
Therefore, it is concluded that consuming different dietary components rather 
than a single component may prove beneficial in combating the burden of weight 
gain as its associated comorbidities.
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